Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 April, 2018 20:48 IST
Strides Shasun receives USFDA nod for Cyproheptadine HCl tablets
Source: IRIS | 12 Apr, 2018, 12.00PM
Comments  |  Post Comment

Strides Shasun today announced that its wholly owned subsidiary Strides Pharma Global has received approval for Cyproheptadine Hydrochloride Tablets USP, 4 mg from the United States Food & Drug Administration (US FDA). Cyproheptadine Hydrochloride Tablets is a generic version of Periactin Tablets of Merck & Co. Inc.

According to IQVIA data, the US market for Cyproheptadine Hydrochloride Tablets USP, 4 mg is approximately USD 20 Million. The product will be manufactured at the company's Oral dosage facility at Bangalore and will be marketed by Strides Pharma Inc. in the US Market.

The company has 74 cumulative ANDA filings with USFDA of which 46 ANDAs have been approved as of date and 28 are pending approval.

Shares of the company declined Rs 8.1, or 1.26%, to trade at Rs 633.75. The total volume of shares traded was 15,613 at the BSE (11.47 a.m., Thursday).



Strides Shasun Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Thermax wins Rs 2.79 bn order for captive cogeneration plant - 26-Apr-2018 16:52
Yes Bank Q4 net jumps 29% to Rs 11.79 bn - 26-Apr-2018 15:25
Supreme Industries quarterly net up 32% - 26-Apr-2018 13:48
Infratel-Indus merger reflects India telco cash pressure: Fitch - 26-Apr-2018 13:44
Infratel-Indus merger reflects India telco cash pressure: Fitch - 26-Apr-2018 13:44
Indiabulls Real Estate quarterly profit zooms 23.69 times - 26-Apr-2018 12:49
Indoco gets UK health regulators nod to supply critical products - 26-Apr-2018 10:05
Zydus receives final approval from USFDA to market 2 drugs - 26-Apr-2018 09:36
Wipro Q4 earnings fall 6.7% q-o-q to Rs 18 bn - 25-Apr-2018 16:23
Sterlite Technologies quarterly profit surges 77% - 25-Apr-2018 15:42
Reliance Nippon Life Asset Management Q4 profit rises 35% to Rs 1.62 bn - 25-Apr-2018 15:34
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer